Allergen Specific IgG
IgG antibodies against allergens appear to confer protection against hypersensitivity reactions. Immunotherapy patients often demonstrate an increase in specific IgG to the allergen used in treatment. An increase in specific IgG levels during immunotherapy is associated with a decrease in sensitivity to the suspect allergen. The degree of the immunological response is dependent on the therapy dosage schedule. Although healthy subjects and untreated allergic patients may demonstrate low levels of specific IgG antibody, patients undergoing immunotherapy with inhalant allergens have been reported to demonstrate up to a 100-fold increase in specific IgG antibody levels after immunotherapy. In addition, increased allergen-specific IgG are seen in food allergies and some severe respiratory allergies like asthma but in less volume.
It has been shown that the IgG4 antibody of four IgG subclasses is a clinically relevant marker of chronic food-immune reactions and possible intestinal permeability which results in adverse reactions to different foods. Symptoms include bloating, headache, fatigue, diarrhea, irritable bowel and other gastroenterological and dermatological conditions. IgG1 antibodies are first responders to new food antigens by binding the antigens and forming complexes. These complexes are either rapidly destroyed by macrophages or activate the complement cascade and attendant inflammation. A continued exposure to the antigen leads to a “class switch” from IgG1 to IgG4 production. IgG4 antigen complexes do not activate the complement cascade. Complexes of IgG4 and food antigens are very stable (long half-life) and alterations in the structure can lead to new antigen forms. IgG1 is then produced to attack this IgG4- antigen-complex. A whole new cycle starts: IgG1→IgG4→complex→modification→IgG1→IgG4. As a result, the complexes can get larger and larger. These larger complexes are able to activate the complement cascade, initiating inflammatory responses in the body. This inflammatory response to a food is the main cause of symptoms in this type of food reaction. The symptoms resulting from food sensitivities, therefore, can come from the activation of complement via IgG1/IgG4 food immune complex. Deposition of these complexes can also occur in tissue or organs, leading to damage. This sequence of events is thought to be the most common way individuals develop adverse reactions to foods they eat on a regular basis.
- Quantitative measurement of allergen-specific IgG in response to specific allergen(s)
- Aid in diagnosis of IgG-mediated allergic disorders
- Aid in diagnosis of food allergies and food allergy disorders such as celiac disease
Positive in:
- Patients with allergic reaction to specific allergen
- Values obtained higher than the reference range indicate that the patient’s allergy response is high when compared to the general population
- Elevated values may be seen in patients showing no symptoms
2 – 200 mg/L (0.2-20mg/dL)
Enzyme-labeled chemiluminescent immunometric assay.
Serum (SST).
Stability
- Ambient: 7 days
- Refrigerated: 14 days
- Frozen: 30 days
3-5 days.
- Am Fam Physician. 2002 Aug 15;66(4):621-4. [PMID: 12201554]
- J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S284-96. [PMID: 20176264]
- J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S687-701. [PMID: 12592314]
- Clin Biochem. 2003 Sep;36(6):453-69. [PMID: 12951171]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757.